About Surgery Partners (NASDAQ:SGRY)
Surgery Partners, Inc. is healthcare services holding company, which engages in the provision of solutions for surgical and related ancillary care in support of its patients and physicians. It operates through the following business segments: Surgical Facility Services; Ancillary Services; and Optical Services. The Surgical Facility Services segment consists of the operation of ambulatory surgery centers and surgical hospitals, and includes the anesthesia services of the company. The Ancillary Services segment operates a diagnostic laboratory and multi-specialty physician practices. The Optical Services segment involves an optical laboratory and an optical products group purchasing organization. The company was founded in 2004 and is headquartered in Nashville, TN.
Industry, Sector and Symbol
Industry General medical & surgical hospitals
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:SGRY
CUSIPN/A
Phone615-234-5900
Debt
Debt-to-Equity Ratio1.59%
Current Ratio1.86%
Quick Ratio1.71%
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual Sales$1.34 billion
Price / Sales0.61
Cash Flow$0.3217 per share
Price / Cash52.07
Book Value$27.41 per share
Price / Book0.61
Profitability
EPS (Most Recent Fiscal Year)($0.84)
Net Income$-52,980,000.00
Net Margins-4.54%
Return on Equity-0.53%
Return on Assets-0.13%
Miscellaneous
Employees10,600
Outstanding Shares48,940,000
Surgery Partners (NASDAQ:SGRY) Frequently Asked Questions
What is Surgery Partners' stock symbol?
Surgery Partners trades on the NASDAQ under the ticker symbol "SGRY."
How will Surgery Partners' stock buyback program work?
Surgery Partners declared that its board has initiated a share buyback program on Saturday, December 16th 2017, which permits the company to buyback $50,000,000.00 in shares, according to EventVestor. This buyback authorization permits the company to reacquire shares of its stock through open market purchases. Stock buyback programs are generally an indication that the company's management believes its shares are undervalued.
How were Surgery Partners' earnings last quarter?
Surgery Partners (NASDAQ:SGRY) issued its quarterly earnings data on Thursday, March, 1st. The company reported ($0.03) EPS for the quarter, missing analysts' consensus estimates of $0.08 by $0.11. The company had revenue of $460.30 million for the quarter, compared to the consensus estimate of $438.30 million. Surgery Partners had a negative return on equity of 0.53% and a negative net margin of 4.54%. The firm's revenue for the quarter was up 50.4% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.35 EPS. View Surgery Partners' Earnings History.
When is Surgery Partners' next earnings date?
What price target have analysts set for SGRY?
8 Wall Street analysts have issued 12-month target prices for Surgery Partners' shares. Their predictions range from $15.00 to $19.00. On average, they anticipate Surgery Partners' share price to reach $17.6667 in the next twelve months. View Analyst Ratings for Surgery Partners.
Who are some of Surgery Partners' key competitors?
Who are Surgery Partners' key executives?
Surgery Partners' management team includes the folowing people:
- Wayne S. DeVeydt, Chief Executive Officer & Director
- Benjamin F. Jacobs, Group President & Group Chief Development Officer
- Bryan S. Fisher, COO-National Group & Executive Vice President
- Robert David Kretschmer, Chief Financial, Strategy & Transformation Officer
- Thomas F. Cowhey, CFO & Principal Accounting Officer
Has Surgery Partners been receiving favorable news coverage?
News headlines about SGRY stock have trended somewhat positive recently, Accern reports. The research group identifies negative and positive news coverage by monitoring more than 20 million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Surgery Partners earned a media sentiment score of 0.12 on Accern's scale. They also assigned news headlines about the company an impact score of 46.68 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the near future.
Who are Surgery Partners' major shareholders?
Surgery Partners' stock is owned by many different of institutional and retail investors. Top institutional shareholders include
DOYLE MICHAEL THOMAS
(6.10%) and
DOYLE MICHAEL THOMAS
(6.10%). Company insiders that own Surgery Partners stock include HIG Surgery Centers, Llc and Jennifer Baldock. View Institutional Ownership Trends for Surgery Partners.
How do I buy shares of Surgery Partners?
Shares of SGRY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Surgery Partners' stock price today?
One share of SGRY stock can currently be purchased for approximately $16.75.
How big of a company is Surgery Partners?
Surgery Partners has a market capitalization of $819.70 million and generates $1.34 billion in revenue each year. The company earns $-52,980,000.00 in net income (profit) each year or ($0.84) on an earnings per share basis. Surgery Partners employs 10,600 workers across the globe.
How can I contact Surgery Partners?
Surgery Partners' mailing address is 310 Seven Springs Way Suite 500, Brentwood TN, 37027. The company can be reached via phone at 615-234-5900 or via email at [email protected]
MarketBeat Community Rating for Surgery Partners (SGRY)
MarketBeat's community ratings are surveys of what our community members think about Surgery Partners and other stocks. Vote "Outperform" if you believe SGRY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SGRY will underperform the S&P 500 over the long term. You may vote once every thirty days.
Surgery Partners (NASDAQ:SGRY) Price Target and Consensus Rating
(How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
8 Wall Street analysts have issued ratings and price targets for Surgery Partners in the last 12 months. Their average twelve-month price target is $17.6667, suggesting that the stock has a possible upside of 5.47%. The high price target for SGRY is $19.00 and the low price target for SGRY is $15.00. There are currently 1 sell rating, 3 hold ratings and 4 buy ratings for the stock, resulting in a consensus rating of "Hold."
| Today | 30 Days Ago | 90 Days Ago | 180 Days Ago |
| Consensus Rating: | Hold | Hold | Hold | Buy |
| Consensus Rating Score: | 2.38 | 2.38 | 2.38 | 2.50 |
| Ratings Breakdown: | 1 Sell Rating(s)
3 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s) | 1 Sell Rating(s)
3 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s) | 1 Sell Rating(s)
3 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s) | 1 Sell Rating(s)
2 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s) |
| Consensus Price Target: | $17.6667 | $18.00 | $18.00 | $18.8333 |
| Price Target Upside: | 5.47% upside | 20.40% upside | 90.48% upside | 66.67% upside |
Surgery Partners (NASDAQ:SGRY) Consensus Price Target History
Surgery Partners (NASDAQ:SGRY) Analyst Ratings History
Show:
(Data available from 4/25/2016 forward)
Surgery Partners (NASDAQ:SGRY) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
(Data available from 1/1/2013 forward)
Surgery Partners (NASDAQ SGRY) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 7.60%
Surgery Partners (NASDAQ SGRY) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 8/31/2017 | H.I.G. Surgery Centers, Llc | Major Shareholder | Sell | 26,455,651 | $19.00 | $502,657,369.00 | |  |
| 8/29/2016 | Jennifer Baldock | VP | Sell | 2,500 | $19.20 | $48,000.00 | 66,983 | |
| 10/21/2015 | H.I.G. Surgery Centers, Llc | Major Shareholder | Sell | 1,324,464 | $19.00 | $25,164,816.00 | | |
| 10/21/2015 | Michael Thomas Doyle | CEO | Sell | 152,966 | $19.00 | $2,906,354.00 | 2,920,487 | |
(Data available from 1/1/2013 forward)
Surgery Partners (NASDAQ SGRY) News Headlines
| Source: |
|
Surgery Partners (NASDAQ:SGRY) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Surgery Partners (NASDAQ:SGRY) Income Statement, Balance Sheet and Cash Flow Statement
Surgery Partners (NASDAQ SGRY) Stock Chart for Wednesday, April, 25, 2018
Loading chart…
